İsrail - İngilizce - Ministry of Health

neopharm (israel) 1996 ltd - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 2000 mg/vial - ceftazidime - ceftazidime is indicated for the treatment of the infections listed below in adults and children includingneonates (from birth).• nosocomial pneumonia• broncho-pulmonary infections in cystic fibrosis• bacterial meningitis• chronic suppurative otitis media• malignant otitis externa• complicated urinary tract infections• complicated skin and soft tissue infections• complicated intra-abdominal infections• bone and joint infections• peritonitis associated with dialysis in patients on capd.treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (turp).the selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic gram negative bacteria (see sections 4.4 and 5.1).ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum of activity.consideration should be given to official guidelines regarding the appropriate use of antibacterial agents

İsrail - İngilizce - Ministry of Health

pharmalogic ltd - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 1 g - ceftazidime - ceftazidime panpharma is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). - nosocomial pneumonia- broncho-pulmonary infections in cystic fibrosis- bacterial meningitis- chronic supportive otitis media- malignant otitis externa- complicated urinary tract infections- complicated skin and soft issues infections- complicated intra-abdominal infections- bone and joint infections- peritonitis associated with dialysis in patients with capdtreatment of patients with bacteremia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing transurethral resection of the prostate (turp).

İsrail - İngilizce - Ministry of Health

pharmalogic ltd - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 2 g - ceftazidime - ceftazidime panpharma is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). - nosocomial pneumonia- broncho-pulmonary infections in cystic fibrosis- bacterial meningitis- chronic supportive otitis media- malignant otitis externa- complicated urinary tract infections- complicated skin and soft issues infections- complicated intra-abdominal infections- bone and joint infections- peritonitis associated with dialysis in patients with capdtreatment of patients with bacteremia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing transurethral resection of the prostate (turp).

Malta - İngilizce - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftazidime pentahydrate - powder for solution for injection - ceftazidime pentahydrate 500 milligram(s) - antibacterials for systemic use

Malta - İngilizce - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftazidime pentahydrate - solution for injection/infusion - ceftazidime pentahydrate 1 gram(s) - antibacterials for systemic use

Malta - İngilizce - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftazidime pentahydrate - powder for solution for injection/infusion - ceftazidime pentahydrate 2 gram(s) - antibacterials for systemic use

Malta - İngilizce - Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftazidime pentahydrate - powder for solution for injection - ceftazidime pentahydrate 500 mg - antibacterials for systemic use

Malta - İngilizce - Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftazidime pentahydrate - solution for injection/infusion - ceftazidime pentahydrate 1 g - antibacterials for systemic use

Malta - İngilizce - Medicines Authority

dali pharma gmbh brehmstrasse 56, 40239, dusseldorf,, germany - ceftazidime pentahydrate - powder for solution for injection/infusion - ceftazidime pentahydrate 2 g - antibacterials for systemic use

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - avibactam sodium, quantity: 543.5 mg (equivalent: avibactam, qty 500 mg); ceftazidime pentahydrate, quantity: 2329.7 mg (equivalent: ceftazidime, qty 2000 mg) - injection, powder for - excipient ingredients: sodium carbonate - zavicefta is indicated for the treatment of the following infections in adults (see sections 4.4 special warnings and precautions for use and 5.1 pharmacodynamic properties):,? complicated intra-abdominal infection (ciai) in combination with metronidazole. ? complicated urinary tract infection (cuti) including pyelonephritis.,? hospital-acquired pneumonia (hap) including ventilator associated pneumonia (vap).,zavicefta is indicated for the treatment of the following infections in infants and paediatric patients (greater than or equal to 3 months to < 18 years) (see sections 4.4 special warnings and precautions for use and 5.1 pharmacodynamic properties):,? complicated intra-abdominal infection (ciai) in combination with metronidazole. ? complicated urinary tract infection (cuti) including pyelonephritis.,consideration should be given to official guidance on the appropriate use of antibacterial agents.,to reduce the development of drug-resistant bacteria and maintain the effectiveness of zavicefta and other antibiotics, zavicefta should be used in combination with an antibacterial agent(s) active against gram-positive and/or anaerobic pathogens when these are known or suspected to be contributing to the infectious process.